Navigation Links
Fitting pieces for biosensors
Date:4/7/2009

whole cells or organisms, or tiny molecules consisting of just a few atoms. The search for the right aptamers is like managing a gigantic molecular dating agency. Using an in vitro method, researchers select the best binding partners for the target molecule from a huge pool of 10 million x 100 million nucleic acids with different sequences. This selection method is called SELEX (Systematic Evolution of Ligands by EXponential enrichment). SELEX is an evolutionary process performed in a 'test tube' (in vitro). Therefore the use of animals, plants or cell cultures is not required during the process. Beside ethical benefits, another advantage of this is the possibility of aptamer selection even for toxic substances. Once suitable binders (aptamers) for a target molecule have been found by the SELEX process and their sequences have been defined, aptamers can be produced very accurately and reliably at any time by chemical synthesis. Accordingly no biologically induced variations have to be taken into account during synthesis, as they would if natural systems were used. Another advantage is the possibility to give the aptamers defined properties relatively easily by sequence modifications or by adding functional groups or reporter molecules. The added properties can enable or simplify the measuring process, or improve the stability of the aptamers.

In the UFZ's biosensor laboratory headed by Dr Beate Strehlitz, Dr Regina Stoltenburg has developed two different modifications of the SELEX method. One of these is known as FluMag SELEX. The 'Flu' stands for fluorescence and refers to the fact that a fluorescence molecule is added to the nucleic acids during the SELEX procedure to make them visible. In this manner the molecules can always be found again and researchers can measure the enrichment of those which exhibit best binding and detecting abilities to the given target. The 'Mag' refers to magnetic beads. These are dust-mote-sized magnetic beads onto which the s
'/>"/>

Contact: Tilo Arnhold
presse@ufz.de
49-341-235-1635
Helmholtz Association of German Research Centres
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications
2. Innovative Biosensors and ProGenTech Partner to Develop a Rapid Diagnostics System
3. Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
4. Model is first to compare performance of biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fitting pieces for biosensors
Fitting pieces for biosensors
Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4
Breaking Biology News(10 mins):University of Washington professor garners Avanti Young Investigator Award 2Vermicompost from pig manure grows healthy hibiscus 2'Fighting' IED attacks with SCARE technology 2'Fighting' IED attacks with SCARE technology 3The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 1The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 2The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 3The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 4Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 1Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 2Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 3deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 1deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 2deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 3